Header Image

News & Resources

News & Resources

News & Resources

Investor & Media Relations

Thomas Staab, Senior Vice President, Chief Financial Officer

investorrelations@biocryst.com

Resources

BioCryst designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. Learn more about our Company